相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Amylin stimulates fatty acid esterification in 3T3-L1 adipocytes
Pierre Miegueu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
Russell A. Miller et al.
NATURE (2013)
Fatty acids revert the inhibition of respiration caused by the antidiabetic drug metformin to facilitate their mitochondrial β-oxidation
M. Mar Gonzalez-Barroso et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2012)
Connecting mTORC1 signaling to SREBP-1 activation
Inan Bakan et al.
CURRENT OPINION IN LIPIDOLOGY (2012)
Regulation of Adipocyte Formation by GLP-1/GLP-1R Signaling
Tenagne Delessa Challa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1
Mingjian Lu et al.
NATURE MEDICINE (2012)
Dipeptidyl-peptidase-IV by cleaving neuropeptide Y induces lipid accumulation and PPAR-γ expression
Joana Rosmaninho-Salgado et al.
PEPTIDES (2012)
Impaired thermogenesis and adipose tissue development in mice with fat-specific disruption of insulin and IGF-1 signalling
Jeremie Boucher et al.
NATURE COMMUNICATIONS (2012)
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials
Tina Vilsboll et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Artepillin C, as a PPARγ ligand, enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells
Sun-Sil Choi et al.
BIOCHEMICAL PHARMACOLOGY (2011)
FoxO transcription factors; Regulation by AKT and 14-3-3 proteins
Guri Tzivion et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
OCT1 Expression in Adipocytes Could Contribute to Increased Metformin Action in Obese Subjects
Jose Maria Moreno-Navarrete et al.
DIABETES (2011)
Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome
Daniela Lamers et al.
DIABETES (2011)
Normal Postprandial Nonesterified Fatty Acid Uptake in Muscles Despite Increased Circulating Fatty Acids in Type 2 Diabetes
Sebastien M. Labbe et al.
DIABETES (2011)
Glitazone-like action of glimepiride and glibenclamide in primary human adipocytes
P. Mayer et al.
DIABETES OBESITY & METABOLISM (2011)
Metformin opposes impaired AMPK and SIRT1 function and deleterious changes in core clock protein expression in white adipose tissue of genetically-obese db/db mice
P. W. Caton et al.
DIABETES OBESITY & METABOLISM (2011)
Study of the Potential Association of Adipose Tissue GLP-1 Receptor with Obesity and Insulin Resistance
Joan Vendrell et al.
ENDOCRINOLOGY (2011)
Effect of insulin analogues on 3t3-l1 adipogenesis and lipolysis
Eva Garcia-Escobar et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2011)
Weight Beneficial Treatments for Type 2 Diabetes
L. F. Meneghini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Dynamics of human adipose lipid turnover in health and metabolic disease
Peter Arner et al.
NATURE (2011)
Effects of Sulfonylureas on Peroxisome Proliferator Activated Receptor. Activity and on Glucose Uptake by Thiazolidinediones
Kyeong Won Lee et al.
DIABETES & METABOLISM JOURNAL (2011)
Mechanisms of metformin action on glucose transport and metabolism in human adipocytes
Jean Grisouard et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Metformin induces glucose uptake in human preadipocyte-derived adipocytes from various fat depots
M. Fischer et al.
DIABETES OBESITY & METABOLISM (2010)
Insulin detemir is a fully efficacious, low affinity agonist at the insulin receptor
A. R. Sorensen et al.
DIABETES OBESITY & METABOLISM (2010)
Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
Katrin Duevel et al.
MOLECULAR CELL (2010)
AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives
B. Viollet et al.
ACTA PHYSIOLOGICA (2009)
Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contents
Masayuki Arakawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
FoxO1 Haploinsufficiency Protects Against High-Fat Diet-Induced Insulin Resistance With Enhanced Peroxisome Proliferator-Activated Receptor γ Activation in Adipose Tissue
Jane J. Kim et al.
DIABETES (2009)
Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis
M. Monami et al.
DIABETES OBESITY & METABOLISM (2009)
DPP-IV inhibition enhances the antilipolytic action of NPY in human adipose tissue
K. Kos et al.
DIABETES OBESITY & METABOLISM (2009)
STATEMENT BY AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CONSENSUS PANEL ON TYPE 2 DIABETES MELLITUS: AN ALGORITHM FOR GLYCEMIC CONTROL
Helena W. Rodbard et al.
ENDOCRINE PRACTICE (2009)
Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells
Sun-Sil Choi et al.
LIFE SCIENCES (2009)
Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone
Robert F. Kushner et al.
OBESITY (2009)
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M. Nathan et al.
DIABETES CARE (2009)
Inhibition of lipolysis by palmitate, H2O2 and the sulfonylurea drug, glimepiride, in rat adipocytes depends on cAMP degradation by lipid droplets
Guenter Mueller et al.
BIOCHEMISTRY (2008)
Rosiglitazone no longer recommended
[Anonymous]
LANCET (2008)
Metformin inhibits intracellular lipid accumulation in the murine pre-adipocyte cell line, 3T3-L1
K. B. Alexandre et al.
DIABETES OBESITY & METABOLISM (2008)
Characteristics of signalling properties mediated by long-acting insulin analogue glargine and detemir in target cells of insulin
Tsutomu Wada et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Long-acting insulin analogues versus NPH human insulin in type 2 diabetes - A meta-analysis
Matteo Monami et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
FGF21 attenuates lipolysis in human adipocytes -: A possible link to improved insulin sensitivity
Peter Arner et al.
FEBS LETTERS (2008)
Metformin induces oxidative stress in white adipocytes and raises uncoupling protein 2 levels
Andrea Anedda et al.
JOURNAL OF ENDOCRINOLOGY (2008)
Future perspectives on glucagon-like peptide-1, diabetes and cardiovascular risk
E. Mannucci et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2008)
Effect of insulin detemir, compared to human insulin, on 3T3-L1 adipogenesis
Anja Boehm et al.
REGULATORY PEPTIDES (2008)
Location, location: protein trafficking and lipolysis in adipocytes
James G. Granneman et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2008)
Control of lipolysis by natriuretic peptides and cyclic GMP
Max Lafontan et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2008)
Fat depot-related differences in gene expression, adiponectin secretion, and insulin action and signalling in human adipocytes differentiated in vitro from precursor stromal cells
S. Perrini et al.
DIABETOLOGIA (2008)
Gliclazide inhibits proliferation but stimulates differentiation of white and brown adipocytes
Norihiko Nakano et al.
JOURNAL OF BIOCHEMISTRY (2007)
Systematic review: Comparative effectiveness and safety of oral medications for type 2 diabetes Mellitus
Shari Bolen et al.
ANNALS OF INTERNAL MEDICINE (2007)
Nicotine-induced activation of AMP-activated protein kinase inhibits fatty acid synthase in 3T3L1 Adipocytes - A role for oxidant stress (Publication with Expression of Concern. See vol. 294, pg. 10025, 2019) (Withdrawn Publication. See vol. 295, pg. 667, 2020)
Zhibo An et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
GLP-1 amplifies insulin signaling by up-regulation of IRβ, IRS-1 and Glut4 in 3T3-L1 adipocytes
Hong Gao et al.
ENDOCRINE (2007)
Suppression of PPAR-γ attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes
Wei Liao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Regulation of triglyceride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue
Kathy Jaworski et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Yan Shu et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Absence of an adipogenic effect of rosiglitazone on mature 3T3-L1 adipocytes: increase of lipid catabolism and reduction of adipokine expression
P. Wang et al.
DIABETOLOGIA (2007)
Glucose and lipid fluxes in the adipose tissue after meal ingestion in hyperthyroidism
G Dimitriadis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Neither LKB1 nor AMPK are the direct targets of metformin
David Grahame Hardie
GASTROENTEROLOGY (2006)
Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome
Dominique Langin
PHARMACOLOGICAL RESEARCH (2006)
Structural and functional consequences of mitochondrial biogenesis in human adipocytes in vitro
I Bogacka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats
V Sancho et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2005)
(D)-β-hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G
AKP Taggart et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Anti-lipolytic action of AMP-activated protein kinase in rodent adipocytes
M Daval et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Sulfonylurea agents exhibit peroxisome proliferator-activated receptor γ agonistic activity
S Fukuen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans
AL Birkenfeld et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
PPARγ in the control of brown adipocyte differentiation
J Nedergaard et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Rosiglitazone improves postprandial triglyceride and free fatty acid metabolism in type 2 diabetes
JPH Van Wijk et al.
DIABETES CARE (2005)
Glimepiride enhances intrinsic peroxisome proliferator-activated receptor-γ activity in 3T3-L1 adipocytes
K Inukai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Thiazolidinediones upregulate fatty acid uptake and oxidation in adipose tissue of diabetic patients
G Boden et al.
DIABETES (2005)
Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial
SR Smith et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes
GD Tan et al.
DIABETOLOGIA (2005)
Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes
LL Nielsen et al.
REGULATORY PEPTIDES (2004)
Drug therapy: Thiazolidinediones
H Yki-Jarvinen
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Insulin detemir - A review of its use in the management of type 1 and 2 diabetes mellitus
TM Chapman et al.
DRUGS (2004)
Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone
L Wilson-Fritch et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Peroxisome proliferator-activated receptor γ in diabetes and metabolism
SM Rangwala et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle
WM He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Effect of thiazolidinediones on body weight in patients with diabetes mellitus
V Fonseca
AMERICAN JOURNAL OF MEDICINE (2003)
Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPARγ hypomorphic mice
H Koutnikova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes
G Boden et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2003)
PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect
S Tunaru et al.
NATURE MEDICINE (2003)
Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes
K Matsusue et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone
L Wilson-Fritch et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Plasma adiponectin plays an important role in improving insulin resistance with glimepiride in elderly type 2 diabetic subjects
T Tsunekawa et al.
DIABETES CARE (2003)
Adipose tissue as a buffer for daily lipid flux
KN Frayn
DIABETOLOGIA (2002)
Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance
M Blüher et al.
DEVELOPMENTAL CELL (2002)
Glucose uptake and insulin action in human adipose tissue - influence of BMI, anatomical depot and body fat distribution
M Stolic et al.
INTERNATIONAL JOURNAL OF OBESITY (2002)
Exendin-4 increases insulin sensitivity via a PI-3-kinase-dependent mechanism: contrasting effects of GLP-1
I Idris et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Regional differences in the response of human pre-adipocytes to PPAR gamma and RXR alpha agonists
CP Sewter et al.
DIABETES (2002)
The mode of action of thiazolidinediones
H Hauner
DIABETES-METABOLISM RESEARCH AND REVIEWS (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
A unique PPARγ ligand with potent insulin-sensitizing yet weak adipogenic activity
S Rocchi et al.
MOLECULAR CELL (2001)
Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance
CJ de Souza et al.
DIABETES (2001)
Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models
ML Villanueva-Peñacarrillo et al.
ENDOCRINE (2001)
Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability
ND Oakes et al.
DIABETES (2001)
Regulation by insulin of gene expression in human skeletal muscle and adipose tissue - Evidence for specific defects in type 2 diabetes
PH Ducluzeau et al.
DIABETES (2001)
Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation
H Miki et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Mechanisms of nutritional and hormonal regulation of lipogenesis
S Kersten
EMBO REPORTS (2001)
Effect of GLP-1 on lipid metabolism in human adipocytes
ML Villanueva-Peñacarrillo et al.
HORMONE AND METABOLIC RESEARCH (2001)
Nutritional regulation of lipid metabolism in human adipose tissue
SW Coppack et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2001)
Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones
L Chao et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction
H Sakoda et al.
DIABETES (2000)
Sulfonylurea sensitivity of adenosine triphosphate-sensitive potassium channels from β cells and extrapancreatic tissues
FM Gribble et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)
Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists
JM Olefsky
JOURNAL OF CLINICAL INVESTIGATION (2000)
Obesity and insulin resistance
BB Kahn et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
MR Owen et al.
BIOCHEMICAL JOURNAL (2000)
Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use
P Kurtzhals et al.
DIABETES (2000)
A new thiazolidinedione, NC-2100, which is a weak PPAR-γ activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice
Y Fukui et al.
DIABETES (2000)
The Pro12Ala polymorphism in PPAR γ2 may confer resistance to type 2 diabetes
K Hara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
MY El-Mir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
